Research article · 11 Jun 2026
Conference abstractPublished 2015
Anti-apoptotic actions of thyroid hormone in cancer cells may limit effectiveness of chemotherapy
Albany Medical College, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Thyroid hormone as L-thyroxine (T4) is anti-apoptotic at physiological concentrations in a number of cancer cell lines. Among the mechanisms of anti-apoptosis activated by T4 is interference with Ser-15 phosphorylation (activation) of p53 and with TNFα/Fas-induced apoptosis, as well as decreased cellular abundance of caspasesand of BAX. Such actions of T4 may oppose pharmaceutical anti-apoptotic strategies. The anti-apoptotic effects of thyroid hormone largely are initiated at a cell surface thyroid hormone receptor on integrin αvβ3. The integrin is amply expressed and activated in cancer cells, but not in nonmalignant, non-dividing cells. Nanoparticulate tetraiodothyroacetic acid (Nanotetrac) opposes actions of thyroid hormone initiated at αvβ3. We have studied the effects of Nanotetrac (10-7 M) in vitro on expression of a panel of apoptosis-relevant cancer cell genes in human breast cancer MDA-MB-231 and human medullary thyroid carcinoma (mTC, CRL-1803) cell lines. CASP2, MCL2L14, DFFA, BAD and Bcl-Xs are pro-apoptotic genes whose expression was stimulated by Nanotetrac; XIAP and MCL1 are anti-apoptotic genes and their transcription in tumor cells was down regulated by Nanotetrac. Nanotetrac blocked the anti-apoptotic action of thyroid hormone in a stilbene-induced model of apoptosis in glioma cells. Thus, thyroid hormone (T4) is an endogenous anti-apoptotic factor that may oppose chemotherapy-induced apoptosis in αvβ3-expressing cancer cells. These actions of T4 have been blocked in vitro by Nanotetrac and rationalize medical induction of euthyroidhypothyroxinemia.
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Regenerative Medicine.
Research article · 8 Aug 2025
Human Umbilical Cord-Derived Mesenchymal Stem Cells in Combination with Small Extracellular Vesicles Prevent the Development of Fibrosis and Cirrhosis and Improve Survival in Wistar Rats Receiving CCl₄
Opinion · 20 Feb 2025
CAR-T Cell Therapy: Expanding Applications beyond Hematologic Malignancies
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Regenerative Medicine
- SubjectEngineering
- BylineArticles whose byline prints “Paul J Davis”
